Analyst Conference Summaries

Biotechnology Investor Aids

Bluebird Bio
BLUE

conference date: August 14, 2024 @ 5:00 AM Pacific Time

2024
Bluebird
Bio
Q4 2023
Bluebird
Bio
Q1 2024
Bluebird
Bio
Q2 2024
 
Mar. 26, 2024 May 9, 2024 Aug. 14, 2024  

Bluebird Bio (BLUE) is a commercial stage biotechnology company specializing in genetic therapies, including Lyfgenia for Sickle Cell Disease.

Bluebird Bio web site


 

Search

More Analyst Conference Pages:

 AGEN
 AGIO
 ALLO
 ALNY
 AMAT
 AMGN
 APRE
 ARWR
 BIIB
 BLRX
 BMY
 CLDX
 CDTX
 GILD
 GLYC
 ILMN
 IMGN
 INCY
 INKT
 INO
 IONS
 MCHP
 MRNA
 PLX
 RETA
 REGN
 RNA
 SAGE
 SYRS
 TSVT
 VSTM
 VRTX
 WBA
       

Disclaimer: My analyst summaries may include both condensations of statements made by company representatives and my own analysis. They are not covered by any warranty. I cannot guarantee anything said by company representatives is true. I try not to make errors, but it is possible. These are my personal notes which I share with other investors and which I use as the basis of my blog and Seeking Alpha articles.

Copyright 2024 William P. Meyers